Additionally, the SPMs resolvin E1 and lipoxin A4 have been reported to inhibit NF-κB activation via sirtuins (Sirt1, Sirt6, and Sirt7) in pulpitis, supporting the therapeutic potential of a Sirt6 activator in periodontitis [31]. The gene discussed is SIRT1; the disease is pulpitis.